Cargando…
M(pro)-targeted anti-SARS-CoV-2 inhibitor-based drugs
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global health emergency. The main protease is an important drug target in coronaviruses. It plays an important role in the processing of viral RNA-translated polyproteins and is highly conserved in the amino acid se...
Autores principales: | She, Zhuxin, Yao, Yinuo, Wang, Conglong, Li, Yi, Xiong, Xiaohui, Liu, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333551/ https://www.ncbi.nlm.nih.gov/pubmed/37455837 http://dx.doi.org/10.1177/17475198231184799 |
Ejemplares similares
-
Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020) -
Discovery of PL(pro) and M(pro) Inhibitors
for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023) -
Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022) -
Newly synthesized M(pro) inhibitors as potential oral anti-SARS-CoV-2 agents
por: Li, Lin, et al.
Publicado: (2021) -
Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 M(pro)
por: Wang, Zhengyuan, et al.
Publicado: (2021)